stock-detail (CLBS)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/23/2017 12:17 pm

4/23/2017 12:17 pm

4/23/2017 12:17 pm

4/23/2017 12:17 pm

4/10/2017 06:17 pm

4/10/2017 06:17 pm

4/10/2017 06:17 pm

4/10/2017 06:17 pm

4/10/2017 12:17 pm

4/10/2017 12:17 pm

4/10/2017 12:17 pm

Caladrius Biosciences Announces Addition of Four Clinical Sites, Including Joslin Diabetes Center, for the Ongoing Phase 2 Study of CLBS03 in T1D

4/3/2017 11:03 am

[GlobeNewswire] - BASKING RIDGE, N.J., April 03, 2017-- Caladrius Biosciences, Inc., a cell therapy company advancing a select therapeutic development pipeline, announces today that four additional clinical sites, including ...

Caladrius Biosciences Announces 2016 Fourth Quarter and Full Year Financial Results

3/17/2017 11:00 am

[GlobeNewswire] - Annual revenue growth of 57% exceeds 2016 financial guidance. Conference call begins today at 8:30 am Eastern time. BASKING RIDGE, N.J., March 17, 2017-- Caladrius Biosciences, Inc., a cell therapy company ...